• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Evotec SE

    4/17/25 6:00:51 AM ET
    $EVO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $EVO alert in real time by email
    6-K 1 tm258969d2_6k.htm FORM 6-K

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of April, 2025

     

    COMMISSION FILE NUMBER 001-34041

     

    Evotec SE
    (Translation of registrant’s name into English)

     

    Essener Bogen 7

    22419 Hamburg

    Germany

    Tel: +49 40 560810
    (Address of principal executive offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F: Form 20-F x Form 40-F ¨

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

     

     

     

     

     

     

    On February 26, 2025, Evotec SE (the “Company”) announced change in Management Board. The Press Release is attached hereto as Exhibit 99.1.

     

    EXHIBIT INDEX

     

    Exhibit Description of Exhibit

    99.1Evotec announces change in Management Board

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of s the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      Evotec SE
         
      By: /s/ Paul Hitchin
        Name: Paul Hitchin
        Title: Chief Financial Officer

     

    Date: April 17, 2025

     

     

     

    Get the next $EVO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EVO

    DatePrice TargetRatingAnalyst
    4/24/2025Sell → Hold
    Deutsche Bank
    10/7/2024Buy → Hold
    Jefferies
    8/8/2024Hold → Sell
    Deutsche Bank
    7/29/2024$15.00 → $6.00Overweight → Equal-Weight
    Morgan Stanley
    7/11/2024Buy → Hold
    Deutsche Bank
    4/12/2024Hold → Buy
    Deutsche Bank
    1/18/2024Sector Perform → Outperform
    RBC Capital Mkts
    6/23/2023$12.00 → $16.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $EVO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Evotec SE upgraded by Deutsche Bank

      Deutsche Bank upgraded Evotec SE from Sell to Hold

      4/24/25 7:18:16 AM ET
      $EVO
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Evotec SE downgraded by Jefferies

      Jefferies downgraded Evotec SE from Buy to Hold

      10/7/24 7:52:16 AM ET
      $EVO
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Evotec SE downgraded by Deutsche Bank

      Deutsche Bank downgraded Evotec SE from Hold to Sell

      8/8/24 8:58:18 AM ET
      $EVO
      Biotechnology: Pharmaceutical Preparations
      Health Care